Health · World
Health · World · 47 stories in 48h · Clear all filters
DiseaseCancer 12Dementia 1Diabetes 2Infectious disease 3Outbreaks & pandemics 2
Health servicesNHS 1
Living wellChildren's health 1Nutrition 8Women's health 1
Treatment and researchDrugs & pharma 6Medical research & trials 5Mental health 2
Cancer 12 More in Cancer
-
Roche gets FDA approval for advanced breast cancer pill
-
RBC Capital downgrades CG Oncology stock rating on regulatory path
-
Reuters
US FDA approves Roche's oral treatment for advanced breast cancer
-
The FDA declined to approve one of biotech’s most closely watched cancer drugsThe regulator told Summit Therapeutics that the lung-cancer drug needs to prove it can help people live longer.
-
'General Hospital' star Cameron Mathison says ‘red flags’ drove him to demand answers before cancer diagnosisCameron Mathison opens up to Fox News Digital about kidney cancer, divorce, wildfire loss and how those struggles…
Nutrition 5 More in Nutrition
-
Reuters
Rhythm drug shows sustained weight reduction in patients with brain damage-related obesity
-
CNBC
Eli Lilly makes a deal outside obesity. Plus, another word of caution on NvidiaEvery weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last…
- Yahoo Finance Singapore Applied Nutrition shares slump as dividend halted until at least FY28
-
Living longer may start with 3 foods a doctor eats every dayCoffee, cacao and raw honey are three foods a Florida physician says he consumes daily to support longevity…
-
Why is Applied Nutrition stock sliding today?
Medical research & trials 5 More in Medical research & trials
-
Australia’s national medical research body advises conditional use of puberty blockers for transgender childrenNew National Health and Medical Research Council guidelines at odds with public hospital bans in Queensland and NT…
-
Lexeo reports interim trial results for PKP2-ACM gene therapy
-
Generate Biomedicines at Jefferies Global Healthcare Conference: pipeline gains
-
Kailera at Jefferies Global Healthcare Conference: obesity pipeline advances
-
Helus Pharma to present Phase 3 depression trial results Monday
Infectious disease 3 More in Infectious disease
-
Bloomberg
Measles' Comeback Could Be Just the StartThe US has lost its long-standing measles eradication status. And this may be just the first public health…
-
Al Jazeera
Antimicrobial resistance could kill 39 million people over 25 years: WHOUN's health agency says growing resistance to antibiotics and other medicines threatens 'future of modern medicine'.
-
Pennsylvania measles cases rise to 1,561, state health department says
Drugs & pharma 3 More in Drugs & pharma
- Yahoo Finance Eli Lilly is trouncing Nvidia — and the weight-loss drug trade is beating AI again
- Yahoo Finance Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The New England Journal of Medicine
-
FDA approves label update for Cytokinetics’ heart drug MYQORZO
Diabetes 2 More in Diabetes
Outbreaks & pandemics 2 More in Outbreaks & pandemics
-
CNBC
Novo says Wegovy injection lowers BMI and obesity rates in children in trialWegovy is already approved to treat obesity in children ages 12 and older, but there are currently no…
-
Al Jazeera
Africa CDC says Ebola outbreak in DR Congo ‘still not under control’'If we don't stop this outbreak now, it would be the worst Ebola outbreak,' Africa CDC director says.
3 sources · Al Jazeera, SABC News, TimesLIVE
Dementia 1 More in Dementia
Other 14
-
NPR
Are your body clocks off? Meet ‘circadian depression’
-
Ministers accused of ‘gambling with safety’ for not knowing cost of NHS maternity unit repairsNHS chiefs said last year that 43% of maternity and neonatal units in England do not meet safety…
-
Woman whose baby died after free birth didn’t know she was pregnant with twins, NSW inquest hearsInquest continues into deaths of four babies born in free births or home births in northern rivers Get…
-
Reuters
Incyte says EU approves oral treatment for chronic skin disease
-
Bloomberg
Lilly Pushes Buying Spree Beyond $32B With Calytrix DealEli Lilly & Co. agreed to buy closely held Calytrix Bio Inc. in a deal that could be…

